Vice President, Strategy & Business Development – Advanced Therapeutics Division

This is a fully remote position, open to applicants in California, +2 more states.

📋 Description

• Take ownership of the complete P&L and overall performance of the Advanced Therapeutics Division.

• Define and refine the multiyear growth strategy, translating it into operational priorities, resource allocations, and measurable results.

• Establish a data- and KPI-focused operational framework across the commercial pipeline, program execution, productivity, innovation, quality, and financial performance.

• Lead the global business development strategy and manage the revenue opportunity pipeline from market development to commercial transition.

• Create a systematic commercial engine aimed at enhancing pipeline quality, deal velocity, conversion rates, forecast accuracy, and strategic account growth.

• Cultivate senior relationships with pharmaceutical and biotechnology customers and spearhead significant opportunities.

• Forge partnerships with customers, technology collaborators, and platform partners.

• Represent Agilent at customer interactions, industry events, and scientific conferences.

• Convert customer, scientific, and market insights into portfolio, R&D, and investment strategies.

• Define the portfolio strategy encompassing RNA oligonucleotides, BioVectra, and related modalities.

• Supervise early-stage R&D and prioritize technology investments.

• Manage strategic marketing, segmentation, positioning, and market development efforts.

• Direct strategic capital allocation across manufacturing capabilities, technology platforms, R&D, and commercial functions.

• Identify and pursue acquisitions, partnerships, licensing opportunities, and strategic investments.

• Co-lead the integration of acquired businesses and capabilities.

• Lead and develop a geographically dispersed, cross-functional team.

• Enhance integration between Colorado and BioVectra operations.

• Collaborate with Operations, Quality, Regulatory, Finance, HR, Legal, Corporate Development, and other enterprise functions.

• Attract and nurture talent, build succession depth, and cultivate a culture centered on customer focus, accountability, collaboration, scientific curiosity, and continuous improvement.

⛳️ Requirements

• A minimum of 15 years of progressive leadership experience in CDMO, biopharma manufacturing, life-sciences tools or services, or a closely related field, including significant executive responsibilities.

• Proven accountability for commercial growth and significant financial results at scale.

• Full P&L ownership is preferred; comparable responsibilities for a major business, portfolio, commercial function, or growth agenda will be considered.

• Extensive understanding of pharmaceutical and biotechnology clients, along with the scientific, regulatory, quality, and economic factors influencing development and manufacturing.

• Relevant experience with nucleic-acid therapeutics, oligonucleotides, RNA, biologics, APIs, peptides, complex chemistry, or other advanced therapeutic modalities.

• Demonstrated success in business development, strategic account management, and the creation and conversion of complex, high-value revenue streams.

• Significant leadership experience in portfolio strategy, strategic marketing, early R&D, or technology selection.

• Operational expertise in capacity, technical transfer, program delivery, quality, productivity, and capital trade-offs.

• Direct involvement in major organic capital decisions and meaningful participation in M&A activities, partnerships, due diligence, and integration processes.

• Proven capacity to integrate resources within a large global matrix and influence executive stakeholders who are not direct reports.

• A Bachelor's degree in a relevant scientific, engineering, or business discipline is required.

• Willingness to travel occasionally.

🏝️ Benefits

• Eligibility for bonus.

• Stock options.

• Comprehensive benefits package.

• Option for remote work.